Fabio
101 lines
9.3 KiB
Markdown
101 lines
9.3 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Prescription Drug Affordability Review Board"
|
||
description: "The act creates the Colorado prescription drug affordability review board (board) in the division of insurance (division) in the department of regulatory agencies as an independent unit of state government, requires the board to perform affordability reviews of prescription drugs, and authorizes the board to establish upper payment limits for prescription drugs the board determines are unaffordable for Colorado consumers. The board is also required to promulgate rules as necessary for its purposes.The board shall determine by rule the methodology for establishing an upper payment limit for a prescription drug. An upper payment limit applies to all purchases of and payer reimbursements for the prescription drug dispensed or administered to individuals in the state in person, by mail, or by other means. Any savings generated for a health benefit plan as a result of an upper payment limit established by the board must be used by the carrier that issued the health benefit plan to reduce costs to consumers, prioritizing the reduction of out-of-pocket costs for prescription drugs.On and after January 1, 2022, the act prohibits, with certain exceptions, any purchase or payer reimbursement for a prescription drug at an amount that exceeds the upper payment limit established by the board for that prescription drug.A person aggrieved by a decision of the board may appeal the decision within 60 days. The board shall consider the appeal and issue a final decision concerning the appeal within 60 days after the board receives the appeal. Final board decisions are subject to judicial review.Any prescription drug manufacturer (manufacturer) that intends to withdraw from sale or distribution within the state a prescription drug for which the board has established an upper payment limit must notify, at least 180 days before the withdrawal:The commissioner;"
|
||
jurisdiction: "us/states/co"
|
||
legislature: "Colorado General Assembly"
|
||
session: "2021A"
|
||
identifier: "SB 21-175"
|
||
citation: "Colorado SB 21-175 (2021A)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Chris Kennedy", "Julie Gonzales", "Sonya Jaquez Lewis", "Yadira Caraveo"]
|
||
version_count: 11
|
||
action_count: 20
|
||
vote_count: 12
|
||
first_action: "2021-03-08T07:00:00+00:00"
|
||
last_action: "2021-06-16T06:00:00+00:00"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/5a89613a-7914-4b19-a0b7-b071d588a307"
|
||
source_url: "http://leg.colorado.gov/bills/sb21-175"
|
||
source_hash: "d20a3359a1418c4a73f055cea2680f953482d4474ce3dd3f73a26708244b1823"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-co"]
|
||
---
|
||
|
||
# Colorado SB 21-175 (2021A) — Prescription Drug Affordability Review Board
|
||
|
||
The act creates the Colorado prescription drug affordability review board (board) in the division of insurance (division) in the department of regulatory agencies as an independent unit of state government, requires the board to perform affordability reviews of prescription drugs, and authorizes the board to establish upper payment limits for prescription drugs the board determines are unaffordable for Colorado consumers. The board is also required to promulgate rules as necessary for its purposes.The board shall determine by rule the methodology for establishing an upper payment limit for a prescription drug. An upper payment limit applies to all purchases of and payer reimbursements for the prescription drug dispensed or administered to individuals in the state in person, by mail, or by other means. Any savings generated for a health benefit plan as a result of an upper payment limit established by the board must be used by the carrier that issued the health benefit plan to reduce costs to consumers, prioritizing the reduction of out-of-pocket costs for prescription drugs.On and after January 1, 2022, the act prohibits, with certain exceptions, any purchase or payer reimbursement for a prescription drug at an amount that exceeds the upper payment limit established by the board for that prescription drug.A person aggrieved by a decision of the board may appeal the decision within 60 days. The board shall consider the appeal and issue a final decision concerning the appeal within 60 days after the board receives the appeal. Final board decisions are subject to judicial review.Any prescription drug manufacturer (manufacturer) that intends to withdraw from sale or distribution within the state a prescription drug for which the board has established an upper payment limit must notify, at least 180 days before the withdrawal:The commissioner;
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Committee Amendment** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/2021a_sb175_h_app_003.pdf)
|
||
2. **Engrossed (05/06/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175_eng.pdf)
|
||
3. **Final Act (06/15/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175_enr.pdf)
|
||
4. **Introduced (03/08/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175_01.pdf)
|
||
5. **PA1 (03/18/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175shhs_01.pdf)
|
||
6. **PA2 (04/30/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175shhsapp.pdf)
|
||
7. **PA3 (05/25/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175app_01.pdf)
|
||
8. **Reengrossed (05/07/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175_ren.pdf)
|
||
9. **Rerevised (06/07/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175_rer.pdf)
|
||
10. **Revised (06/04/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/documents/2021A/bills/2021a_175_rev.pdf)
|
||
11. **Signed Act (06/16/2021)** (committee substitute) — [source](http://leg.colorado.gov/sites/default/files/2021a_175_signed.pdf)
|
||
|
||
## Votes
|
||
|
||
- REPASS — **18–16** (pass) · upper
|
||
- AMD — **23–39** (fail) · lower
|
||
- permission for 3rd — **17–18** (fail) · upper
|
||
- BILL — **19–16** (pass) · upper
|
||
- COW * — **17–17** (fail) · upper
|
||
- COW * — **20–14** (pass) · upper
|
||
- REPASS — **19–15** (pass) · upper
|
||
- AMD — **23–39** (fail) · lower
|
||
- AMD — **23–39** (fail) · lower
|
||
- CONCUR — **34–0** (pass) · upper
|
||
- BILL — **41–22** (pass) · lower
|
||
- AMD — **24–38** (fail) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Chris Kennedy — primary (person)
|
||
- Julie Gonzales — primary (person)
|
||
- Sonya Jaquez Lewis — primary (person)
|
||
- Yadira Caraveo — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2021-06-16T06:00:00+00:00** Governor Signed `executive-signature`
|
||
- **2021-06-15T06:00:00+00:00** Sent to the Governor `executive-receipt`
|
||
- **2021-06-15T06:00:00+00:00** Signed by the Speaker of the House
|
||
- **2021-06-15T06:00:00+00:00** Signed by the President of the Senate
|
||
- **2021-06-08T06:00:00+00:00** Senate Considered House Amendments - Result was to Pass
|
||
- **2021-06-08T06:00:00+00:00** Senate Considered House Amendments - Result was to Reconsider
|
||
- **2021-06-08T06:00:00+00:00** Senate Considered House Amendments - Result was to Concur - Repass
|
||
- **2021-06-07T06:00:00+00:00** House Third Reading Passed - No Amendments `passage, reading-3`
|
||
- **2021-06-04T06:00:00+00:00** House Second Reading Special Order - Passed with Amendments - Committee, Floor
|
||
- **2021-06-03T06:00:00+00:00** House Second Reading Special Order - Laid Over Daily - No Amendments
|
||
- **2021-05-27T06:00:00+00:00** House Second Reading Laid Over Daily - No Amendments
|
||
- **2021-05-25T06:00:00+00:00** House Committee on Appropriations Refer Amended to House Committee of the Whole `committee-passage, referral-committee`
|
||
- **2021-05-19T06:00:00+00:00** House Committee on Health & Insurance Refer Unamended to Appropriations `referral-committee`
|
||
- **2021-05-11T06:00:00+00:00** Introduced In House - Assigned to Health & Insurance `introduction`
|
||
- **2021-05-07T06:00:00+00:00** Senate Third Reading Passed - No Amendments `passage, reading-3`
|
||
- **2021-05-06T06:00:00+00:00** Senate Second Reading Passed with Amendments - Committee, Floor `reading-2`
|
||
- **2021-05-04T06:00:00+00:00** Senate Second Reading Laid Over Daily - No Amendments
|
||
- **2021-04-30T06:00:00+00:00** Senate Committee on Appropriations Refer Amended to Senate Committee of the Whole `committee-passage, referral-committee`
|
||
- **2021-03-17T06:00:00+00:00** Senate Committee on Health & Human Services Refer Amended to Appropriations `referral-committee`
|
||
- **2021-03-08T07:00:00+00:00** Introduced In Senate - Assigned to Health & Human Services `introduction`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/5a89613a-7914-4b19-a0b7-b071d588a307`. Confidence: reported (aggregated from official Colorado legislature records).
|
||
|